Based on the clinical data, I think KERX deserves to go down tomorrow. But it won’t surprise me unduly if Weiss spins the results enough to make the stock go up, at least temporarily.
One poster on Yahoo predicts clear sailing to $80 a share, unless the company is acquired sooner. Another poster on SI (of all places) has already accused me of being a market manipulator for posting skeptically about the new data.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”